Literature DB >> 2621101

Asymptomatic intrathoracic extramedullary hematopoiesis: a report of three cases.

T Murakami, A C Dixon, R C Ho, J M Nakamura.   

Abstract

Extramedullary hematopoiesis (EMH) is observed in people suffering from severe anemia of prolonged duration and appears to be a compensatory mechanism for disturbed medullary hematopoiesis. The hemoglobinopathies (such as thalassemia, spherocytosis, and sickle cell disease), neoplastic diseases such as leukemia and lymphoma, and others, including myelofibrosis and osteitis fibrosa cystica, are associated with EMH. These diseases and their resultant anemia have in common the ability to stimulate erythropoietin production, which in turn may stimulate hematopoiesis in organs of mesenchymal origin. The liver and spleen are the most common sites of EMH; however, other sites, including the falx cerebri, thoracic cavity, retroperitoneal area and pelvis have been reported. When present, intrathoracic EMH is most frequently associated with thalassemia. Spinal cord compression and hemothorax have also been reported as complications of intrathoracic EMH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621101

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN: 0017-8594


  3 in total

1.  Paratracheal extramedullary hematopoiesis.

Authors:  C Kurtman; M K Ozbilgin; M N Andrieu; B Celebioğlu
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

Review 2.  Paraspinal extramedullary hematopoiesis in hereditary spherocytosis with a concurrent follicular lymphoma: case report and review of the literature.

Authors:  Ricardo Molina-Urra; Daniel Martinez; Amaia Sagasta; Ana Carrio; Xavier Setoain; Benet Nomdedeu; Elias Campo
Journal:  Diagn Pathol       Date:  2015-09-15       Impact factor: 2.644

3.  Paraspinal and presacral extramedullary hematopoiesis: a rare manifestation of polycythemia vera.

Authors:  Kaleem Ahmad; Sajid Ansari; Roshan Koirala; Meenu Agarwal; Shatdal Chaudhary
Journal:  Iran J Radiol       Date:  2013-08-30       Impact factor: 0.212

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.